Literature DB >> 3524424

Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin.

M G Bergeron, Y Bergeron.   

Abstract

Multiple factors may modify the pharmacokinetics of aminoglycosides and increase their nephrotoxic potential. In this study, we investigated the influence of Escherichia coli endotoxin on the renal handling of several aminoglycosides and one cephalosporin. Drug levels in the renal parenchyma, as well as several parameters of renal function and histology, were compared in rats treated with endotoxin (0.25 mg/kg) and normal rats treated with either gentamicin (10 mg/kg), netilmicin (10 mg/kg), tobramycin (10 mg/kg), amikacin (50 mg/kg), or cephalothin (100 mg/kg). Blood pressure and pulse rate were recorded. Endotoxin was associated with a decrease in the half-life and in the apparent volume of distribution of gentamicin. The endotoxin-injected animals accumulated significantly (P less than 0.05) more aminoglycosides in their kidneys than the normal animals. The amount of cephalothin recovered in the renal parenchyma was identical in both groups. Slight decreases in the glomerular filtration rate and renal plasma flow were observed after endotoxin treatment. Blood pressure and cardiac frequency were minimally affected by endotoxin. No histological lesions were observed by light microscopy in animals receiving endotoxin. Thus, endotoxin modifies the renal handling of aminoglycosides in the absence of any major physiological disturbance or histological change. By increasing the total amount of drug within the kidneys, endotoxin might increase the nephrotoxic potential of aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524424      PMCID: PMC180354          DOI: 10.1128/AAC.29.1.7

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Effects of bacterial endotoxin on lysosomal and mitochondrial enzyme activities of established cell cultures.

Authors:  A McGivney; S G Bradley
Journal:  J Reticuloendothel Soc       Date:  1979-09

2.  Affinity of endotoxin for membranes.

Authors:  J W Shands
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

3.  Influence of single or multiple doses of gentamicin and netilmicin on their cortical, medullary, and papillary distribution.

Authors:  M G Bergeron; S Trottier
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

4.  Lysosomal disruption during the development of endotoxic shock in the baboon.

Authors:  P M Jansön; S H Kühn; J J Geldenhuys
Journal:  S Afr Med J       Date:  1975-06-21

5.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.

Authors:  J C Mathison; R J Ulevitch
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

6.  Experimental lipid A-induced nephritis in the dog.

Authors:  M Westenfelder; C Galanos; P O Madsen
Journal:  Invest Urol       Date:  1975-03

7.  Neutralization of endotoxin toxicity in chick embryos by antibiotics.

Authors:  D Rifkind; J D Palmer
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

8.  Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis due to Escherichia coli.

Authors:  M G Bergeron; S Trottier; C Lessard; D Beauchamp; P M Gagnon
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

9.  Increased nephrotoxicity of gentamicin in pyelonephritic rats.

Authors:  D Beauchamp; A Poirier; M G Bergeron
Journal:  Kidney Int       Date:  1985-08       Impact factor: 10.612

10.  Autoradiography of gentamicin uptake by the rat proximal tubule cell.

Authors:  F J Silverblatt; C Kuehn
Journal:  Kidney Int       Date:  1979-04       Impact factor: 10.612

View more
  14 in total

1.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Intrarenal distribution of vancomycin in endotoxemic rats.

Authors:  M Ngeleka; P Auclair; D Tardif; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  Endotoxin-tobramycin additive toxicity on renal proximal tubular cells in culture.

Authors:  V Joly; Y Bergeron; M G Bergeron; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

4.  Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.

Authors:  P Van der Auwera; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

5.  Granulocyte colony-stimulating factor enhances endotoxin-induced decrease in biliary excretion of the antibiotic cefoperazone in rats.

Authors:  M Nadai; I Matsuda; L Wang; A Itoh; K Naruhashi; T Nabeshima; M Asai; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Increased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapy.

Authors:  M Tardif; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  Influence of endotoxin on the intracortical accumulation kinetics of gentamicin in rats.

Authors:  D Tardif; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

8.  Autoradiography of tobramycin uptake by the proximal and distal tubules of normal and endotoxin-treated rats.

Authors:  M G Bergeron; Y Bergeron; Y Marois
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

9.  Prolonged endotoxemia enhances the renal injuries induced by gentamicin in rats.

Authors:  P Auclair; D Tardif; D Beauchamp; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

10.  Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis.

Authors:  P Auclair; C Lessard; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.